Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00779142 · ClinicalTrials.gov registry record · NA
Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies
A NA study, sponsored by Wake Forest University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT00779142: Clinical Trial NA study, sponsored by Wake Forest University.
NCT00779142 is a NA study that was terminated before completion, run by Wake Forest University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00779142, a NA study, was terminated before completion, sponsored by Wake Forest University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
It is well known that blindness is one of the most feared disabilities expressed by patients in the United States. Estimates of the economic impact of visual disability in the current population exceed 30 million US dollars in this country alone. The reasons for this figure are many; however age related macular degeneration (ARMD), diabetic retinopathy, glaucoma and uveitis are responsible for the majority of permanent visual disability and hence the costs in both quality of life and placing an economic burden on society. Research that may help reverse various abnormal biological responses that lead to or worsen clinical manifestations of diabetic retinopathy would be valuable.
Interventions
- DRUG Methotrexate intravenous 25mg/ml
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-08 |
| Phase | NA |
Why NCT00779142 stopped before completion
NCT00779142 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Methotrexate intravenous 25mg/ml is the first listed.
NCT00779142 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00779142 about?
NCT00779142 is a clinical study titled "Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies". It is well known that blindness is one of the most feared disabilities expressed by patients in the United States. Estimates of the economic impact of visual disability in the current population exceed 30 million US dollars in this country alone. The reasons for this figure are many; however age rel...
What is the current status of trial NCT00779142?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2011-09. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00779142?
The interventions under investigation include: Methotrexate intravenous 25mg/ml (DRUG).
Who is sponsoring clinical trial NCT00779142?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00779142's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia